Skip to main content

Find Clinical Trials

Home
Conditions
Paraproteinemias

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,006 public trials 571 recruiting studies

Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Stage I Multiple Myeloma Treatment

NCT00733538

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Service de Medecine interne, Hôpital l'ARCHET, CHU de Nice Nice, France

View Trial Details

Completed

A Real-World Study of Bispecific Antibodies in Multiple Myeloma

NCT06359067

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Assistance Publique - Hôpitaux de Paris (AP-HP) Paris, IDF, France

View Trial Details

Completed

Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)

NCT03848845

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: GSK Investigational Site Atlanta, Georgia, United States

GSK Investigational Site Indianapolis, Indiana, United States

GSK Investigational Site Charlotte, North Carolina, United States

GSK Investigational Site Madison, Wisconsin, United States

View Trial Details

Completed

Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide

NCT06069024

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +16 more
Locations: the First Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China

View Trial Details

Completed

Daratumumab Provided at Home Experience An Open, Single-center, Mixed-method Project.

NCT05306587

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Odense University Hospital Odense, Denmark

View Trial Details

Completed

Bone Healing During Ninlaro Exposure

NCT04028115

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Odense University Hospital Odense, Denmark

View Trial Details

Completed

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

NCT01588015

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +198 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma Patients

NCT02812706

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Investigational Site Number :392001 Nagoya, Aichi-ken, Japan

Investigational Site Number :392005 Shibukawa-shi, Gunma, Japan

Investigational Site Number :392010 Hiroshima, Japan

Investigational Site Number :392015 Kanazawa, Ishikawa-ken, Japan

View all 13 locations

View Trial Details

Completed

Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment

NCT03450057

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: General Hospital of Athens "Alexandra" Athens, Attica, Greece

View Trial Details

Completed

Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy

NCT02891811

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie Graz, Austria

Med. Universität Innsbruck, Univ.-Klinik f. Innere Medizin V, Hämatologie u. Onkologie Innsbruck, Austria

Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik Kufstein, Austria

LKH Hochsteiermark - Standort Leoben Abteilung für Innere Medizin und Hämatologie und internistische Onkologie Leoben, Austria

View all 21 locations

View Trial Details